ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=(E2-independent) E3 ubiquitin-conjugating enzyme FATS {ECO:0000305}; EC=2.3.2.- {ECO:0000269|PubMed:24240685};AltName: Full=Centrosomal protein C10orf90 homolog {ECO:0000305};AltName: Full=E2/E3 hybrid ubiquitin-protein ligase FATS { | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
644
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:160788
Li Z, et al., An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis. Oncogene. 2010 May 6;29(18):2659-71
J:175329 Zhang X, et al., FATS is a transcriptional target of p53 and associated with antitumor activity. Mol Cancer. 2010;9:244 J:265621 Yan S, et al., FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage. Oncogene. 2014 Nov 20;33(47):5424-33 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/18/2025 MGI 6.24 |
![]() |
|